Retatrutide, a experimental dual stimulator of the GLP-1 binding site and glucose-dependent insulinotropic polypeptide (GIP) binding site , is exhibiting promising data in initial patient studies. https://dailybookmarkhit.com/story21450907/retatrutide-emerging-research-and-possible-therapeutic-applications